A combination TLR7/8 and RIG-I agonist adjuvant reverts asthmatic allergic sensitization and prevents aggravated influenza infection in mice
Molecular Therapy Advances
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитирование
A combination TLR7/8 and RIG-I agonist adjuvant reverts asthmatic allergic sensitization and prevents aggravated influenza infection in mice. // Molecular Therapy Advances. – URL: https://www.sciencedirect.com/science/article/pii/S3117387X26002259?dgcid=rss_sd_all
A combination TLR7/8 and RIG-I agonist adjuvant reverts asthmatic allergic sensitization and prevents aggravated influenza infection in mice. Molecular Therapy Advances. https://www.sciencedirect.com/science/article/pii/S3117387X26002259?dgcid=rss_sd_all
“A combination TLR7/8 and RIG-I agonist adjuvant reverts asthmatic allergic sensitization and prevents aggravated influenza infection in mice.” Molecular Therapy Advances.
@article{article90253,
title = {A combination TLR7/8 and RIG-I agonist adjuvant reverts asthmatic allergic sensitization and prevents aggravated influenza infection in mice},
journal = {Molecular Therapy Advances},
url = {https://www.sciencedirect.com/science/article/pii/S3117387X26002259?dgcid=rss_sd_all}
}